Hims & Hers plots wellness-and-longevity pivot beyond weight-loss meds
TL;DR Summary
Hims & Hers, the telehealth company built on selling GLP-1 weight-loss drugs online, plans a pivot into wellness and longevity, including potentially FDA-regulated peptides. The founder-CEO aims to source peptides in the U.S. and lean on its mass-marketing platform to push broader wellness products, signaling a transition from prescription-focused care toward a broader wellness business amid regulatory scrutiny.
Hims & Hers CEO is plotting new ways to upend traditional health care The Washington Post
Reading Insights
Total Reads
0
Unique Readers
9
Time Saved
21 min
vs 22 min read
Condensed
99%
4,331 → 58 words
Want the full story? Read the original article
Read on The Washington Post